- Guideline for the treatment of breakthrough and the prevention of refractory chemotherapy‐induced nausea and vomiting in children with cancer (open access at Pediatric Blood and Cancer)
- Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients
- Update (available at Pediatric Blood and Cancer) NEW!
- Original Guideline (open access at Pediatric Blood and Cancer)
- Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients
- Focused Update (open access at Pediatric Blood and Cancer)
- Quick Summary (PDF) Updated!
- Original Guideline (open access at Pediatric Blood and Cancer)
- Quick Summary (PDF)
- Focused Update (open access at Pediatric Blood and Cancer)
- Classification of the acute emetogenicity of chemotherapy in pediatric patients: A clinical practice guideline
- Update (open access at Pediatric Blood and Cancer)
- Original Guideline (open access at Pediatic Blood and Cancer)
- Quick Summary (PDF)
- Dexamethasone dosing for prevention of acute chemotherapy‐induced vomiting in pediatric patients: A systematic review (available in early view at Pediatric Blood and Cancer)
If you have any questions about any of the POGO guidelines, our development processes or guidelines under development, please email:
Paula Robinson, MD, MSc
Guideline Methodologist and Program Manager